ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 428 filers reported holding ENCOMPASS HEALTH CORP in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,285,225 | -0.8% | 242,484 | 0.0% | 0.02% | +5.6% |
Q2 2023 | $16,418,592 | +1.7% | 242,484 | -18.8% | 0.02% | -5.3% |
Q1 2023 | $16,145,929 | +3.1% | 298,446 | +14.0% | 0.02% | 0.0% |
Q4 2022 | $15,661,847 | +32.0% | 261,860 | -0.2% | 0.02% | +26.7% |
Q3 2022 | $11,868,000 | -19.4% | 262,389 | -0.1% | 0.02% | -16.7% |
Q2 2022 | $14,726,000 | -29.6% | 262,723 | -10.7% | 0.02% | -14.3% |
Q1 2022 | $20,915,000 | +72.6% | 294,125 | +58.4% | 0.02% | +75.0% |
Q4 2021 | $12,116,000 | -22.4% | 185,652 | -10.8% | 0.01% | -29.4% |
Q3 2021 | $15,621,000 | -16.4% | 208,164 | -13.1% | 0.02% | -15.0% |
Q2 2021 | $18,694,000 | +44.2% | 239,572 | +51.4% | 0.02% | +33.3% |
Q1 2021 | $12,963,000 | +1.4% | 158,273 | +2.3% | 0.02% | -6.2% |
Q4 2020 | $12,790,000 | +1278900.0% | 154,676 | +813984.2% | 0.02% | – |
Q4 2019 | $1,000 | 0.0% | 19 | +26.7% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 15 | +50.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 10 | -44.4% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 18 | -40.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |